WAM
WST icon

Wolverine Asset Management’s West Pharmaceutical WST Stock Holding History

Wolverine Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-174
Closed -$62K – 2401
2021
Q2 		$62K Buy
+174
New +$57.5K ﹤0.01% 1608

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wolverine Asset Management's WST Position: Q3 2021 in Review

Wolverine Asset Management sold out of West Pharmaceutical (WST) in Q3 2021, closing a stake of 174 shares — an estimated $62K sold.

Wolverine Asset Management first reported a position in WST in Q2 2021 and held it in 1 quarter. The position peaked at $62K in Q2 2021. 669 funds tracked by Wall St. Rank hold WST as of Q3 2021.

  • Wolverine Asset Management reported no remaining West Pharmaceutical position as of Q3 2021 after selling out during the quarter.
  • Wolverine Asset Management sold 174 West Pharmaceutical shares in Q3 2021, an estimated $62K.
  • Wolverine Asset Management first reported a position in West Pharmaceutical in Q2 2021 and held it in 1 quarter.
  • Wolverine Asset Management's West Pharmaceutical position peaked at $62K in Q2 2021.
  • 669 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2021.

Based on Wolverine Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.